tailieunhanh - Molecular pathology testing for non-small cell lung cancer: An observational study of elements currently present in request forms and result reports and the opinion of different stakeholders

For patients with non-small cell lung cancer (NSCLC), targeted therapies are becoming part of the standard treatment. It is of question which information the clinicians provide on test requests and how the laboratories adapt test conclusions to this knowledge and regulations. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN